Cūrza and the University of Florida Expand Collaboration to Include Bacterial Biothreats with DTRA Award
News provided by
Share this article
Share this article
SALT LAKE CITY, April 1, 2021 /PRNewswire/ Cūrza Global, LLC (Cūrza) announced today that The Institute for Therapeutic Innovation (ITI) at the University of Florida has been awarded a $75M contract from the Defense Threat Reduction Agency (DTRA) in partnership with Cūrza. This program is aimed at the development of Cūrza s CZ-02 platform of antibiotics for the treatment of drug-resistant bacterial infections. The CZ-02 platform represents a novel class of antibacterial agents with a unique mode of action.